Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ADMA Biologics Inc. (ADMA)

2.85   -0.08 (-2.73%) 07-01 16:00
Open: 2.9 Pre. Close: 2.93
High: 2.94 Low: 2.83
Volume: 2,815,853 Market Cap: 246M
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.944 - 2.965 2.965 - 2.981
Low: 2.777 - 2.804 2.804 - 2.826
Close: 2.812 - 2.849 2.849 - 2.878

Technical analysis

as of: 2020-07-01 4:29:46 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.67     One year: 3.97
Support: Support1: 2.73    Support2: 2.27
Resistance: Resistance1: 3.14    Resistance2: 3.40
Pivot: 2.94
Moving Average: MA(5): 2.93     MA(20): 2.96
MA(100): 2.91     MA(250): 3.72
MACD: MACD(12,26):     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 45.59     %D(3): 51.96
RSI: RSI(14): 46.70
52-week: High: 5.48  Low: 1.45  Change(%): -20.6
Average Vol(K): 3-Month: 274718  10-Days: 239640

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ADMA has closed above bottom band by 20.8%. Bollinger Bands are 71.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADMA's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 26 Jun 2020
ADMA Biologics Inc. (ADMA) recently have taken one step ahead with the beta value of 2.06 - News Daemon

Thu, 25 Jun 2020
Fresh Data-Based Insight On ADMA Biologics, Inc. (ADMA) - Stocks Register

Thu, 25 Jun 2020
ADMA Biologics Inc (ADMA) Stock: Buy, Hold, or Sell? - InvestorsObserver

Wed, 24 Jun 2020
Analysts Say ADMA Biologics, Inc. (NASDAQ:ADMA) Can Really Get to $15 in 12 Months - Marketing Sentinel

Tue, 23 Jun 2020
Hedge Funds Have Never Been This Bullish On ADMA Biologics Inc (ADMA) - Yahoo Finance

Tue, 23 Jun 2020
BRIEF-ADMA Biologics Announces Martha J. Demski Elected To Board Of Directors - Reuters

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 86
Shares Float (M) 68
% Held by Insiders 7.35
% Held by Institutions 47.91
Shares Short (K) 9,210
Shares Short P. Month (K) 9,680

Stock Financials

EPS -0.890
EPS Est This Year -1.740
EPS Est Next Year -1.080
Book Value (p.s.) 1.120
Profit Margin -151.18
Operating Margin -124.89
Return on Assets (ttm) -19.5
Return on Equity (ttm) -102.4
Qtrly Rev. Growth 189.1
Gross Profit (p.s.) -0.118
Sales Per Share 0.417
EBITDA (p.s.) -0.483
Qtrly Earnings Growth
Operating Cash Flow (M) -87
Levered Free Cash Flow (M) -70

Stock Valuations

PE Ratio -3.20
PEG Ratio
Price to Book value 2.54
Price to Sales 6.83
Price to Cash Flow -2.84

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.